DIRS.INFO The most relevant business & tech news

☆ Traders seeing possible opportunity in Starbucks and high-yield bonds ahead of Thursday's session
▼ + stars: | 2024-10-24 | by ( Frank Holland | In Frank-Holland | ) www.cnbc.com time to read: +2 min

(This is a wrap-up of the key money moving discussions on CNBC's "Worldwide Exchange" exclusive for PRO subscribers. Plus, they are reacting to Tesla earnings and watching an interesting bond opportunity outside of Treasuries. Worldwide Exchange pick: Starbucks Earlier this week, Starbucks (SBUX) pulled its profit outlook and said sales last quarter tumbled in a release of preliminary results. Opportunity in high yield bonds Joanna Gallegos of BondBloxx said while Treasury yields are higher since the Federal Reserve rate cut in September, she is seeing the best opportunity in high yield bonds. She recommended high yield bond ETFs: BondBloxx CCC Rated USD High Yield Corporate Bond ETF (XCCC) with a yield above 10% and the BondBloxx BB Rated USD High Yield Corporate Bond ETF (XBB) with a yield above 6%.

Persons: Tesla, George Gianarikas, Cannaccord Genuity, Matt Powers, Brian Niccol, Joanna Gallegos, BondBloxx, Gallegos Organizations: PRO, Worldwide, Starbucks, Powers Advisory, Federal Locations: Treasuries

☆ CNBC Daily Open: Apple upgrades Siri with AI
▼ + stars: | 2024-06-11 | by ( Abid Ali | ) www.cnbc.com time to read: +3 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Apple IntelligenceShares of Apple fell 1.9% after the iPhone maker delivered its long-awaited AI strategy. Siri will get an upgrade with Apple Intelligence and access to OpenAI's ChatGPT. Investors are concerned Apple had fallen behind its rivals, Microsoft and Google, in the race to deliver AI services and tools.

Persons: Goldman Sachs, Siri, Apple, Elon Musk's, Chris Ailman, CNBC's, Ailman, CalSTRS, Elliott, Moderna, Tesla, Elon, Bernstein Organizations: CNBC, Nasdaq, Technology, Nvidia, Meta, Microsoft, Dow Jones, Apple Intelligence, Apple, Investors, Google, California State Teachers, Elliott, Southwest, Elliott Management, Southwest Airlines, Boeing, Pfizer, Novavax Locations: U.S

☆ Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
▼ + stars: | 2024-06-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. Moderna's messenger RNA combination shot, called mRNA-1083, is made up of both the company's vaccine candidate for seasonal influenza and a newer, "next-generation" version of its Covid shot. The study compared the combination shot with an enhanced flu vaccine called Fluzone HD and Moderna's currently licensed Covid shot, Spikevax, in one group of patients ages 65 and above. Moderna is also developing a combination shot targeting the flu and RSV, and another vaccine targeting all three respiratory viruses: Covid, flu and RSV. Meanwhile, Pfizer and BioNTech also are studying a vaccine that targets both Covid and the flu in a late-stage trial.

Persons: Stephane Bancel, Novavax, Bancel, Moderna, BioNTech Organizations: Pfizer, Novavax, Moderna, Covid Locations: U.S

☆ CDC advisers recommend spring Covid boosters for older adults
▼ + stars: | 2024-02-28 | by ( Erika Edwards | ) www.cnbc.com time to read: +3 min

The panel's vote to recommend spring boosters for older adults is not final until CDC Director Dr. Mandy Cohen signs off on it. The additional dose should be given at least four months after a previous dose for healthy older adults, or at least three months after a Covid infection. Covid hospitalizations peaked at the beginning of January, with 35,000 hospitalizations a week. By Feb. 7, Covid hospitalizations had fallen to around 20,000 a week. The vast majority have been among older adults, 65 and older.

Persons: Covid —, there's, Megan Wallace, Mandy Cohen, Marvia Jones, Covid, Covid hospitalizations Organizations: Centers for Disease Control, Prevention, CDC, Kansas City Health Department Locations: agency's, Kansas, Missouri, United States

Omicron subvariant JN.1 is causing nearly all new coronavirus cases in the U.S., according to estimates from the Centers for Disease Control and Prevention. The strain, which was responsible for just over 3% of infections in mid-November, has virtually taken over the COVID-19 variant scene in the U.S. in recent months. It was responsible for more than 96% of new infections over the past two weeks, according to the estimates . JN.1, which is closely related to BA.2.86, or “pirola,” is also the top variant globally. But the levels, which reflect both symptomatic and asymptomatic infections, are trending downward.

Organizations: subvariant, Centers for Disease Control, World Health Organization, WHO, CDC Locations: U.S

The latest COVID-19 wave in the U.S. appears to have peaked and started retreating, but concerns over a new variant are always lurking. Data indicates the latest increase in COVID-19 activity was significantly lower – and significantly less dangerous – than the COVID-19 surges the U.S. saw early in the pandemic. There are also concerns beyond just surviving a coronavirus infection, such as long COVID and the risks posed by reinfection . Meanwhile, as is always the case with COVID-19, there’s the possibility a new variant could change everything. Yet despite those changes, existing immunity from vaccines and previous infections still provides good protection,” the CDC said.

Persons: That’s, ” Maria Van Kerkhove, we're, ”, reinfection, ” Van Kerkhove, ” JN Organizations: Centers for Disease Control, World Health Organization, CDC, Washington Post Locations: U.S, –, COVID, South Africa

☆ When Covid-19 finally got me, here’s what I did next
▼ + stars: | 2024-02-12 | by ( Katia Hetter | ) edition.cnn.com time to read: +9 min

Story highlights Getting a Covid-19 vaccination reduces risk of hospitalization or death All should have a plan in the event of infection, our medical expert advises There are treatments available for patients not eligible for PaxlovidCNN —Covid-19 finally got me. There are more key points I want to emphasize: The Covid-19 vaccine is not going to protect you 100% from contracting the virus. That’s because the viral load may not be high enough initially to trigger a positive test. You should also consider getting tested for the flu, as antiviral treatments are available for influenza, too. Wen: Individuals who test positive should stay home for at least five days and isolate from others, according to CDC guidance.

Persons: Paxlovid CNN —, I’ve, “ Hamilton, Leana Wen, Wen, it’s, It’s, Joe Raedle, Covid Organizations: Paxlovid CNN, CNN Health, World Health, WHO, George Washington University, CNN, Covid, US Centers for Disease Control, Paxlovid Locations: naps, Covid

☆ Fact Check: Iceland has not banned COVID vaccines
▼ + stars: | 2023-11-30 | by ( Reuters Fact Check | ) www.reuters.com time to read: +2 min

A headline shared online falsely claims that Iceland has banned COVID-19 vaccines and cites sudden deaths for which there is no evidence, according to the Icelandic national health authority. Iceland has not banned COVID vaccines and “there are no soaring sudden deaths,” Guðrún Aspelund, chief epidemiologist at the Icelandic Directorate of Health, told Reuters in a Nov. 29 email. In 2021, Iceland along with other Scandinavian countries temporarily discontinued giving some COVID vaccines to younger adults. As of Oct. 5, 80.5% of the population (archived) in Iceland has received the primary course, that is two doses of a COVID vaccine. Iceland has not banned COVID vaccines and vaccination is recommended for specific groups of the population.

Persons: ” Guðrún Aspelund, epidemiologist, Aspelund, Moderna's Spikevax, Read Organizations: Icelandic Directorate of Health, Reuters, Twitter, Facebook, Health, Iceland’s, Pfizer, BioNTech's, Thomson Locations: Iceland

☆ Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
▼ + stars: | 2023-11-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +10 min

In this article PFEMRNANVAX Follow your favorite stocks CREATE FREE ACCOUNTA sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder | ReutersThree years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine. Experts and vaccine makers can agree that low Covid vaccination rates are concerning, even as cases of the virus dwindle from their pandemic highs. However, Iovine of the University of Florida doesn't believe combination shots will have a significant effect on Covid vaccination rates. If combination shots don't do the trick, it's unclear what else could boost Covid vaccination rates down the line.

Persons: Brian Snyder, Ali Mokdad, Mokdad, Irfan Khan, Jennifer Kates, Brad Pollock, Nicole Iovine, epidemiologist, Iovine, Michael Yee, Albert Bourla, Arpa Garay, Garay, John Trizzino, Trizzino, Jamey Mock, Andrew Pekosz, Jefferies, Yee, doesn't Organizations: Walgreens, Reuters, Pfizer, Moderna, Centers for Disease Control, CDC, University of Washington, CVS Pharmacy, Los Angeles Times, KFF, UC Davis Health's, University of Florida, Jefferies, Arpa, CNBC, Istock, Getty, Johns Hopkins Bloomberg School of Public Health Locations: Somerville , Massachusetts, U.S, Novavax, Covid, Eagle Rock , California

☆ New COVID Variant Takes Hold in the United States
▼ + stars: | 2023-11-28 | by ( Nov. | At A.M. | ) www.usnews.com time to read: +2 min

By Robin Foster HealthDay Reporter(HealthDay)TUESDAY, Nov. 28, 2023 (Healthday News) -- The prevalence of a highly mutated COVID variant has tripled in the past two weeks, new government data shows. Now, nearly 1 in 10 new COVID cases are fueled by the BA.2.86 variant, the U.S. Centers for Disease Control and Prevention reported Monday. Scientists first warned of the highly mutated variant back in August, but it has since spread in several regions of the United States. The CDC also noted that BA.2.86 variant poses a "low" public health risk. But the CDC data released Monday did show that emergency department visits linked to COVID-19 have begun to climb nationwide.

Persons: Robin Foster HealthDay, Jasmine Reed Organizations: U.S . Centers for Disease Control, EG, WHO, CDC, CBS News, JN Locations: New York, New Jersey, United States, U.S

WASHINGTON (AP) — Americans can order more free COVID-19 tests online for home delivery. Anyone who did not order a batch of four COVID-19 tests in September can secure up to eight of them this time around starting Monday at COVIDtests.gov. The new release of free COVID-19 nasal swab tests also comes ahead of the first winter since the pandemic started that insurers are no longer required to cover the cost of them. Political Cartoons View All 1256 ImagesThe Food and Drug Administration also approved updated COVID-19 vaccines in September in the hopes of revving up protection for Americans this winter. U.S. taxpayers have spent tens of billions of dollars to develop COVID-19 tests, vaccines and treatments in the three years since the pandemic started.

Organizations: WASHINGTON, U.S . Postal Service, Drug Administration Locations: U.S, COVIDtests.gov, COVID, United States

Over 16,200 new COVID-19 hospital admissions were reported last week – an increase of more than 8% over the week prior. CDC continues to monitor HV.1, EG.5 and all other lineages.”HV.1 was responsible for 29% of new COVID-19 cases in recent weeks, according to estimates from the CDC. Updated COVID-19 vaccines are expected to work on HV.1, which is a descendant of EG.5. Political Cartoons on Women’s Issues View All 73 ImagesNearly 15% of American adults have received the updated COVID-19 shot, according to a survey from the federal government. While the COVID-19 vaccine coverage so far is comparable to the last updated COVID-19 vaccine, it’s still lower than experts were hoping for ahead of the holiday season.

Persons: “, EG Organizations: Centers for Disease Control, CDC, EG Locations: U.S

☆ CDC to expand disease surveillance at four major US airports to include flu, RSV
▼ + stars: | 2023-11-06 | by ( Manav Tanneeru | Amanda Musa | ) edition.cnn.com time to read: +5 min

CNN —The US Centers for Disease Control and Prevention is expanding its infectious disease surveillance program at four major US airports to more than 30 pathogens, including flu, RSV and other respiratory viruses. The program currently operates Covid-19 surveillance at seven major international airports in the United States. The traveler surveillance program was introduced in 2021 when the CDC began collecting nasal swab samples from anonymous international travelers arriving at participating airports who volunteer to get swabbed. The program has collected samples from travelers from more than 135 countries and has sequenced more than 14,000 samples for further analysis. The wastewater program, which was introduced in August 2022, collects wastewater from a single plane using a custom-made collection device.

Persons: Dr, Cindy Friedman, John F, “, ” Friedman, Friedman, Ginkgo Bioworks, Matthew McKnight, ” McKnight, Sanjay Gupta, Deidre McPhillips Organizations: CNN, Centers for Disease Control, CDC’s, Health, Boston Logan International Airport, San Francisco International Airport, Dulles International, Washington , D.C, Kennedy International, CDC, Get CNN, CNN Health Locations: United States, Washington ,, New York, Ginkgo

NEW YORK (AP) — A month after federal officials recommended new versions of COVID-19 vaccines, 7% of U.S. adults and 2% of children have gotten a shot. The data also indicated that nearly 40% of adults said they probably or definitely will not get the shot. In the late summer, government health officials made the nation's COVID-19 vaccination campaign more like the annual flu campaign. Even so, health officials say about 18,000 hospitalization and 1,200 deaths are still being reported each week. ___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group.

Persons: didn't, hospitalizations, Camille Kotton, David Kimberlin, “ Organizations: Centers for Disease Control, CDC, Harvard Medical School, University of Alabama, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: U.S, Birmingham

☆ Over 7 million Americans have gotten updated COVID vaccines
▼ + stars: | 2023-10-12 | by ( Patrick Wingrove | ) www.reuters.com time to read: +2 min

Millions of doses of another updated COVID vaccine from Novavax (NVAX.O) have also been made available to Americans this week, according to the company. Last year's booster targeting the original virus and another variant was rolled out about 10 days earlier. By Sept. 28, 2022, almost 7.6 million Americans had received the updated shots. U.S. public health officials have been optimistic that Americans will get the new vaccines and have recommended that everyone ages 6 months and older receive one. About 17% of the U.S. population, or 56.5 million people, ultimately received last year's version of the vaccines.

Persons: Emily Elconin, Patrick Wingrove, Bill Berkrot Organizations: REUTERS, U.S . Department of Health, Human Services, Pfizer, Moderna, U.S . Centers, Disease Control, Thomson Locations: Waterford , Michigan, U.S, Moderna, Novavax

☆ Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
▼ + stars: | 2023-10-07 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +6 min

The biotech company is banking on sales of its updated Covid vaccine — its only commercially available product — and a broad cost-cutting push to help it stay afloat. Novavax's shot fends off the virus with protein-based technology, a decades-old method used in routine vaccinations against hepatitis B and shingles. The federal government shifted Covid vaccine distribution and coverage to the private market for the first time this fall. A sign advertises COVID-19 (coronavirus) vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, August 14, 2023. Some pharmacies, like Walgreens , also appear to be resolving supply disruptions, which left many stores without any new Covid shots for patients to receive.

Persons: Patrick Van Katwijk, Novavax, aren't, Mayank Mamtani, fends, Silvia Taylor, Taylor, Novavax's, Mamtani, Hannah Beier, Jefferies, Roger Song, Brian Snyder, Biden Organizations: Dutch Health Service Organization, Getty, Pfizer, Moderna, Drug Administration, Riley Securities, CNBC, Covid, FDA, Bloomberg, Insurance, Walgreens, Reuters Locations: The Hague, Netherlands, U.S, Schwenksville , Pennsylvania, Somerville , Massachusetts

The summer increase of COVID-19 appears to have passed its peak. The mindset change is likely how health officials will examine COVID-19 during the fall and winter months for years to come. Last winter saw a peak of new weekly COVID-19 hospital admissions at nearly 44,500. That would mean that the U.S. enters peak respiratory disease season with an elevated level of COVID-19 circulating already, so a further increase could be possible on top of that. But to get the most protection against this form of the COVID virus that's circulating right now, get the updated COVID vaccine."

Persons: Ashish Jha, ”, – COVID, don’t, Andrew Pekosz, It’s, Mandy Cohen, ” Pekosz, “ pirola, it's, Biden, ” Cohen, Cohen, – Organizations: White, for Disease Control, CDC, Johns Hopkins Bloomberg School of Public Health Locations: U.S, hospitalizations, Boston

☆ FDA authorizes updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.
▼ + stars: | 2023-10-03 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

"In the coming days, individuals in the U.S. can go to major pharmacies, physicians' offices, clinics and various government entities to receive an updated Novavax vaccine." Last month, the FDA and CDC greenlit XBB.1.5 shots from Pfizer and Moderna for all Americans ages six months and older. The end of that declaration means all three manufacturers will sell their updated shots directly to health-care providers and vie for commercial market share. That includes the Biden administration's Bridge Access Program, which will provide Covid vaccines at no cost to underinsured and uninsured people. It's unclear how many Americans will actually roll up their sleeves and take the new vaccines from Novavax, Pfizer and Moderna.

Persons: Novavax, John Jacobs, fends, Demetre Daskalakis, Biden, it's, Eris, Megan Wallace Organizations: Drug Administration, Pfizer, Moderna, Centers for Disease Control, Covid, FDA, CDC, EG, Biden Locations: U.S, Novavax

A vial labelled "Novavax COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. The Maryland-based company, whose COVID vaccine is its lone marketed product, has adopted cost-cutting measures and is counting on commercial sales of its updated shot to help it stay afloat. The CDC's Advisory Committee on Immunization Practices (ACIP) will not meet again to discuss the Novavax shot, a spokesperson said. Novavax's original COVID shot received U.S. authorization in July 2022, long after Pfizer and Moderna vaccines were in use. All three of the updated shots target the XBB.1.5 variant of the coronavirus.

Persons: Dado Ruvic, BioNTech, COVID, John Jacobs, Jacobs, Sriparna Roy, Bill Berkrot Organizations: REUTERS, U.S . Food, Drug Administration, U.S . Centers for Disease Control, Prevention, Pfizer Inc, Moderna, FDA, Pfizer, Moderna's, Thomson Locations: U.S, Maryland, Bengaluru

A nurse fills a syringe with malaria vaccine before administering it to an infant at the Lumumba Sub-County hospital in Kisumu, Kenya, July 1, 2022. REUTERS/Baz Ratner/File photo Acquire Licensing RightsGENEVA, Oct 2 (Reuters) - The World Health Organization (WHO) recommended on Monday the use of a second malaria vaccine to curb the life-threatening disease spread to humans by some mosquitoes. recommended the broad use of the world's first malaria vaccine called RTS,S," WHO chief Tedros Adhanom Ghebreyesus told a briefing in Geneva. "Today, it gives me great pleasure to announce that WHO is recommending a second vaccine called R21/Matrix-M to prevent malaria in children at risk of the disease." "GSK has always recognised the need for a second malaria vaccine, but it is increasingly evident that RTS,S, the first ever malaria vaccine and the first ever vaccine against a human parasite, set a strong benchmark," GSK said in a statement.

Persons: Baz Ratner, Tedros Adhanom Ghebreyesus, Tedros, Poonawalla, Takeda, Hanna Nohynek, Gabrielle Tétrault, Farber, Leroy Leo, Gareth Jones, Mark Potter Organizations: Lumumba, REUTERS, Rights, World Health Organization, WHO, Britain's University of Oxford, UNICEF, Serum Institute of India, Reuters, GSK plc, United Nations, GSK, Takeda Pharmaceuticals, Thomson Locations: Kisumu, Kenya, Geneva, Ghana, Malawi, Bengaluru

☆ Europe to decide on Novavax's COVID vaccine in October
▼ + stars: | 2023-09-21 | by ( ) www.reuters.com time to read: +1 min

Four vials with the "Nuvaxovid" COVID-19 vaccine from Novavax are pictured in Saabruecken, Germany, February 26, 2022. REUTERS/Frank Simon/File photo Acquire Licensing RightsSept 21 (Reuters) - The European Medicines Agency (EMA) expects to decide on the use of Novavax's (NVAX.O) updated COVID-19 vaccine in October, its director Emer Cooke said on Thursday. The agency had started the evaluation process for the protein-based shot on Aug. 24, Cooke said at a press conference. EU regulators recently gave the green light for an updated COVID-19 vaccine from Pfizer (PFE.N) and its German partner BioNTech (22UAy.DE), which targets the XBB.1.5 variant of Omicron. Moderna's (MRNA.O) updated shot is also on track to win approval.

Persons: Frank Simon, Emer Cooke, Cooke, BioNTech, Novavax, Bhanvi, Michael Erman, Saumyadeb Chakrabarty Organizations: REUTERS, European Medicines Agency, Pfizer, U.S . Food, Drug Administration, FDA, Moderna, Thomson Locations: Saabruecken, Germany, United States, Bengaluru, New York

COVID-19 deaths and hospitalizations have been on the rise in the U.S. as fall approaches. Nearly 845 coronavirus deaths were reported for the week ending Aug. 19, according to provisional data from the Centers for Disease Control and Prevention. That’s up from about 520 deaths a month prior. Meanwhile, COVID-19 hospitalizations have been increasing in the U.S. for nine weeks, reaching more than 20,500 new hospital admissions during the week ending Sept. 9 – an increase of nearly 8% from the prior week. While the totals are smaller than in previous waves of the virus in the U.S., they mark noteworthy trends heading into the fall and winter seasons.

Persons: ” Peter Marks, ” Organizations: Centers for Disease Control, CDC, ”, Food, Drug Administration’s, Biologics, Research, EG Locations: U.S, COVID

☆ Meet the Black students who were instrumental in developing the first Covid-19 shots
▼ + stars: | 2023-09-15 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +10 min

Among about two dozen scientists in Graham’s lab were three young students: Olubukola Abiona, Geoffrey Hutchinson and Cynthia Ziwawo. What the world didn’t know at the time was that those three students — Abiona, Hutchinson and Ziwawo — were doing the foundational work for those vaccines to eventually save lives. Geoffrey Hutchinson served in the Peace Corps and taught chemistry to high school students in Mozambique. The fruits of Abiona, Hutchinson and Ziwawo’s labor were evident this week as the United States began to roll out updated versions of the Moderna and Pfizer/BioNTech Covid-19 vaccines. Abiona, Hutchinson and Ziwawo all confirmed Wednesday that although they haven’t made their appointments yet, they plan to get the updated shots.

Persons: Barney Graham’s, Olubukola Abiona, Geoffrey Hutchinson, Cynthia Ziwawo, “, Graham, ‘, ’ ”, Hutchinson, ”, ” Ziwawo, Anthony Fauci, — Abiona, Ziwawo —, Ziwawo, Kizzmekia Corbett, ” Corbett, David Satcher, he’s, Valerie Montgomery Rice, “ They’re, Abiona, Hannah Montana, Austin Steele, CNN Abiona, BioNTech, “ It’s, Dr, Sanjay Gupta Organizations: CNN, Vaccine Research, National Institutes of Health, University of Washington, “, Vaccine Research Center, National Institute of Allergy, Diseases, Moderna, Morehouse School of Medicine, David Satcher Global Health Equity Institute, Association of American Medical Colleges, NIH, Disney, David Satcher Global Health Equity Summit, KPMG LLP, Indiana University School of Medicine, Case Western Reserve University, Peace Corps, United States, Pfizer, CNN Health, FDA, Food and Drug Administration, US Centers for Disease Control Locations: China, Bethesda , Maryland, Ziwawo, United States, Atlanta, Graham’s, Nigeria, Mozambique, Abiona, United

☆ It's Time to Start Preparing Against Flu, RSV & COVID-19
▼ + stars: | 2023-09-15 | by ( Sept. | At A.M. | ) www.usnews.com time to read: +5 min

The flu vaccine is now available in some locations. And new respiratory syncytial virus (RSV) vaccines are recommended for some. "We should do what we can to protect ourselves — and others — with the best tool we have: the flu vaccine." Not only that, but COVID-19 and RSV could again spike at the same time as the flu, triggering a "tripledemic," Gandhi said. Women who are between 32 and 36 weeks pregnant can also protect their infants at birth by getting a new Pfizer RSV vaccine.

Persons: Cara Murez HealthDay, Soniya Gandhi, Gandhi, There's, Priya Soni, Sinai Guerin Children’s, Soni, Sonja Rosen, Rosen Organizations: Southern Hemisphere, U.S . Food, Drug Administration, Pfizer, GSK, U.S . Centers for Disease Control Locations: United States, Cedars, Sinai, Los Angeles, U.S, Guillain, Barre

☆ ICON to partner with US govt agency to test COVID vaccine candidates
▼ + stars: | 2023-09-13 | by ( ) www.reuters.com time to read: +1 min

Vials labelled "VACCINE Coronavirus COVID-19" and a syringe are seen in front of a displayed U.S. flag in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsCompanies Icon Plc FollowBioNTech SE FollowModerna Inc Follow Show more companiesSept 13 (Reuters) - Contract research firm ICON Plc (ICLR.O) said on Wednesday it is partnering with the U.S. government for a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates. As part of the collaboration with Biomedical Advanced Research and Development Authority, ICON will conduct a mid-stage trial of 10,000 participants to assess the efficacy of a next generation COVID-19 vaccine relative to currently available shots. The U.S. agency will select the vaccine candidate for the trial. The U.S. Food and Drug Administration on Monday authorized updated COVID-19 vaccines from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O) that target the XBB.1.5 subvariant of the virus.

Persons: Dado Ruvic, Pratik Jain, Saumyadeb Chakrabarty, Shounak Organizations: REUTERS, U.S, Research, Development Authority, U.S . Food, Drug Administration, Pfizer, Moderna, Thomson Locations: U.S, Bengaluru

Search resuls for: "XBB"

25 mentions found